IP Library › Assignment 046337/0252
Patent Assignment
Reel/Frame 046337/0252

Security Interest

Recorded: 2018-07-12 Pages: 13
Assignors
MABVAX THERAPEUTICS HOLDINGS, INC.
Executed: 2018-07-03
MABVAX THERAPEUTICS, INC.
Executed: 2018-07-03
Assignee
OXFORD FINANCE LLC, AS COLLATERAL AGENT AND AS A LENDER
133 NORTH FAIRFAX STREET, ALEXANDRIA, VIRGINIA, 22314
Covered Properties (7)
Nucleic Acids Encoding Human Antibodies To Sialyl-Lewis a
Application: 61/870,137 →
Nucleic Acids Encoding Human Antibodies To Sialyl-Lewis A
Patent: 9,475,874 →
Application: 14/468,827 →
Publication: US 2015/0056134
Nucleic Acids Encoding Human Antibodies to Sialyl-Lewis A
Application: 15/275,174 →
Publication: US 2017/0015756
Human Monoclonal Antibodies to Ganglioside GD2
Application: 62/007,874 →
Human Monoclonal Antibodies to Ganglioside GD2
Patent: 9,856,324 →
Application: 14/730,036 →
Publication: US 2015/0353645
Nucleic Acids Encoding Human Antibodies to Sialyl-Lewis A
Human Monoclonal Antibodies to Ganglioside GD2
Related Assignments (9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 18, 2014
From: SAWADA, RITSUKO; SUN, SHU-MAN; SCHOLZ, WOLFGANG
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 032233/0750 →
Assignment of Assignor's Interest Nov 13, 2014
From: SAWADA, RITSUKO; SUN, SHU-MAN; SCHOLZ, WOLFGANG
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 034168/0480 →
Assignment of Assignor's Interest Apr 15, 2015
From: SCHOLZ, WOLFGANG; SAWADA, RITSUKO
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 035419/0343 →
Assignment of Assignor's Interest Aug 10, 2015
From: SCHOLZ, WOLFGANG; SAWADA, RITSUKO
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 036291/0269 →
Assignment of Assignor's Interest Dec 15, 2015
From: SCHOLZ, WOLFGANG; SAWADA, RITSUKO
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 037296/0710 →
Assignment of Assignor's Interest Jun 21, 2019
From: SAWADA, RITSUKO; SUN, SHU-MAN; SCHOLZ, WOLFGANG
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 049556/0001 →
Assignment of Assignor's Interest Jun 26, 2019
From: MABVAX THERAPEUTICS, INC.
To: BIONTECH RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 049586/0362 →
Change of Address in Recorded Assignment Jan 31, 2020
From: MABVAX THERAPEUTICS, INC.
To: BIONTECH RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 051762/0305 →
Assignment of Assignor's Interest Sep 18, 2025
From: BIONTECH RESEARCH AND DEVELOPMENT, INC.
To: BIONTECH SE
Reel/Frame 072302/0591 →